Healthcare Economics & Policy

The Trump administration is reportedly considering requiring hospitals and other healthcare providers to publish the prices they charge insurance companies for services after the rates have been negotiated, The Wall Street Journal reported.

Consumers are more into convenient options when it comes to just about any industry, but in healthcare, the preference has led to national growth in freestanding emergency departments (FSEDs).

Mothers who gave birth twice were more likely to switch to another hospital after the first birth if they received a surprise bill following care, according to a recent study published in Health Affairs.

Drug manufacturer Eli Lilly plans to offer a half-priced version of its insulin medication Humalog, the company announced March 4.

Health insurers selling their services through Healthcare.gov denied nearly one-fifth of claims in 2017. And only a tiny fraction of the affected consumers—less than one-half of one percent—appealed the decisions.

As hospitals start to publish prices of their services, patients should theoretically be able to save money by shopping around. However, out-of-pocket costs to patients have little correlation with the amount insurers pay or the overall price of a procedure, according to a recent study of 14 representative Massachusetts hospitals by Pioneer Institute.

Physicians are major drivers of hospital revenue, generating about $2.4 million each year, according to a new survey from Merritt Hawkins.

The Department of Justice has asked a judge to approve the $69 billion merger between CVS Health and Aetna, which was closed by the two companies at the end of 2018, Reuters reported. The deal has been hung up on court approval, though it has been approved by all other regulators and the DOJ.

More employers are actively integrating or considering integrating their medical, pharmacy, dental, vision and/or disability benefits under their health and wellness programs in the next five years thanks to the positive impact on employees, a study from Anthem found. 

General Electric Company (GE) is selling its biopharma business to Danaher for $21.4 billion, the company announced Feb. 25. With a definitive agreement signed between the two parties, GE’s previous plan to spin off its healthcare sector with its own initial public offering is likely put on hold, GE Chairman and CEO Larry Culp told CNBC.

The use of low-value procedures is harming patients, consuming hospital resources and delaying care for patients for whom the services would be appropriate, according to a new assessment of seven low-value procedures published in JAMA Internal Medicine.

A proposed merger between two major health insurance providers ended in a messy breakup after antitrust issues prohibited the roughly $50 billion transaction in 2017. Now, the two companies, Anthem and Cigna, are still disputing which company will foot the costs of the failed deal, Bloomberg Quint reported.